Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does MEDROXYPROGESTERONE Cause Anaphylactic reaction? 65 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 65 reports of Anaphylactic reaction have been filed in association with MEDROXYPROGESTERONE (Provera). This represents 0.8% of all adverse event reports for MEDROXYPROGESTERONE.

65
Reports of Anaphylactic reaction with MEDROXYPROGESTERONE
0.8%
of all MEDROXYPROGESTERONE reports
0
Deaths
24
Hospitalizations

How Dangerous Is Anaphylactic reaction From MEDROXYPROGESTERONE?

Of the 65 reports, 24 (36.9%) required hospitalization, and 21 (32.3%) were considered life-threatening.

Is Anaphylactic reaction Listed in the Official Label?

Yes, Anaphylactic reaction is listed as a known adverse reaction in the official FDA drug label for MEDROXYPROGESTERONE.

What Other Side Effects Does MEDROXYPROGESTERONE Cause?

Meningioma (1,364) Drug dose omission by device (510) Device leakage (500) Incorrect dose administered by device (410) Drug ineffective (403) Off label use (390) Syringe issue (354) Needle issue (346) Headache (288) Device occlusion (284)

What Other Drugs Cause Anaphylactic reaction?

OMALIZUMAB (3,110) RITUXIMAB (1,747) INFLIXIMAB (1,588) METHOTREXATE (1,524) IBUPROFEN (1,385) ADALIMUMAB (1,358) ETANERCEPT (1,127) ROCURONIUM (971) ACETAMINOPHEN (970) DICLOFENAC (890)

Which MEDROXYPROGESTERONE Alternatives Have Lower Anaphylactic reaction Risk?

MEDROXYPROGESTERONE vs MEDROXYPROGESTERONE\MEDROXYPROGESTERONE MEDROXYPROGESTERONE vs MEFENAMIC ACID MEDROXYPROGESTERONE vs MEFLOQUINE MEDROXYPROGESTERONE vs MEGESTROL MEDROXYPROGESTERONE vs MEGLUMINE

Related Pages

MEDROXYPROGESTERONE Full Profile All Anaphylactic reaction Reports All Drugs Causing Anaphylactic reaction MEDROXYPROGESTERONE Demographics